Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study.

MLA

Bonafede, Machaon M. K., et al. “Factors Associated with the Initiation of Disease-Modifying Antirheumatic Drugs in Newly Diagnosed Rheumatoid Arthritis: A Retrospective Claims Database Study.” Clinical Therapeutics, vol. 34, no. 2, Feb. 2012, pp. 457–67. EBSCOhost, https://doi.org/10.1016/j.clinthera.2011.12.016.

APA

Bonafede, M. M. K., Fox, K. M., Johnson, B. H., Watson, C., & Gandra, S. R. (2012). Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study. Clinical Therapeutics, 34(2), 457–467. https://doi.org/10.1016/j.clinthera.2011.12.016

Chicago

Bonafede, Machaon M K, Kathleen M Fox, Barbara H Johnson, Crystal Watson, and Shravanthi R Gandra. 2012. “Factors Associated with the Initiation of Disease-Modifying Antirheumatic Drugs in Newly Diagnosed Rheumatoid Arthritis: A Retrospective Claims Database Study.” Clinical Therapeutics 34 (2): 457–67. doi:10.1016/j.clinthera.2011.12.016.